Work

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Year: 2018

Type: article

Source: Cancer Treatment and Research Communications

DOI: 10.1016/j.ctarc.2018.04.005

Authors: P.N. Lara Jr., M. Plets, C. Tangen, E. Gertz, N.J. Vogelzang, M. Hussain, P.W. Twardowski, M.G. Garzotto, J.P. Monk, M. Carducci, A. Goldkorn, P.C. Mack, I. Thompson, M. Van Loan, D.I. Quinn

Institutions: University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, Western Human Nutrition Research Center, University of California, Davis, Northwestern University, City Of Hope National Medical Center, Oregon Health & Science University, The Ohio State University, Johns Hopkins University, USC Norris Comprehensive Cancer Center, The University of Texas at San Antonio Health Science Center

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Abbott Laboratories, Sanofi, National Institutes of Health, National Cancer Institute, Cairo University, National Cancer Institute

Awards: G1548551769, G1938688226, G2865536383, UCDCCC NCTN U10 Program, G34995465, G4405169367, Biochemical markers of bone turnover in metastatic prostate cancer, NCI NCTN- Network Lead Academic Participating Site: USC, G6655234369, G776903742, G9000097678, G9000182598, G963521225

OpenAlex ID: W2802961857

FWCI: 0.169

Cites: 20

Cited by: 4

Related to: 10